lysophosphatidic acid has been researched along with Adenomatous Polyposis Coli in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hall, RA; Lee, SJ; Ritter, SL; Shim, H; Yun, CC; Zhang, H | 1 |
1 other study(ies) available for lysophosphatidic acid and Adenomatous Polyposis Coli
Article | Year |
---|---|
MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.
Topics: Adenocarcinoma; Adenomatous Polyposis Coli; Animals; Cell Movement; Colonic Neoplasms; Disease Models, Animal; Genes, APC; GTP-Binding Protein alpha Subunits, G12-G13; GTP-Binding Protein alpha Subunits, Gq-G11; HCT116 Cells; Humans; Inositol Phosphates; JNK Mitogen-Activated Protein Kinases; Lysophospholipids; Membrane Proteins; Mice; Neoplasm Invasiveness; NF-kappa B; Phospholipase C beta; Phosphoproteins; Receptors, Lysophosphatidic Acid; RNA Interference; Signal Transduction; Sodium-Hydrogen Exchangers; Time Factors; Tissue Array Analysis; Transfection | 2011 |